June 15, 2026 · Form 4 insider transaction
Quinlan Paul T sold 733 shares of Oruka Therapeutics, Inc. at $69.69 per share, a transaction worth $51.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.